Covered recipient · General Payments record
ANAM BAIG
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2024
$1,296.28
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $849.55 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $510.85 | 21 |
| Neurocrine BioSciences, Inc. | $66.58 | 4 |
| Neurelis, Inc. | $36.98 | 2 |
| Microtransponder, Inc. | $36.89 | 1 |
| JAZZ PHARMACEUTICALS INC. | $34.82 | 1 |
| Philips Electronics North America Corporation | $29.55 | 1 |
| Aucta Pharmaceuticals, Inc. | $28.15 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.59 | 1 |
| EMD Serono, Inc. | $22.26 | 1 |
| REVANCE THERAPEUTICS, INC. | $20.98 | 1 |
| Lilly USA, LLC | $18.30 | 1 |
| PFIZER INC. | $17.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.56 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264385 | CMS |
| ABBVIE INC. | $27.43 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264387 | CMS |
| ABBVIE INC. | $31.85 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264389 | CMS |
| ABBVIE INC. | $26.03 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264391 | CMS |
| ABBVIE INC. | $15.79 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264393 | CMS |
| ABBVIE INC. | $33.05 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264395 | CMS |
| ABBVIE INC. | $30.33 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264397 | CMS |
| ABBVIE INC. | $28.76 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264399 | CMS |
| ABBVIE INC. | $29.39 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264401 | CMS |
| ABBVIE INC. | $27.78 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264403 | CMS |
| ABBVIE INC. | $19.04 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264405 | CMS |
| ABBVIE INC. | $23.35 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264407 | CMS |
| ABBVIE INC. | $24.01 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264409 | CMS |
| ABBVIE INC. | $21.06 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264411 | CMS |
| ABBVIE INC. | $31.75 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264413 | CMS |
| ABBVIE INC. | $27.09 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264415 | CMS |
| ABBVIE INC. | $21.64 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264417 | CMS |
| ABBVIE INC. | $20.07 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264419 | CMS |
| ABBVIE INC. | $15.63 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264421 | CMS |
| ABBVIE INC. | $24.57 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264423 | CMS |
| ABBVIE INC. | $16.67 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103264425 | CMS |
| Aucta Pharmaceuticals, Inc. | $28.15 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147907090 | CMS |
| EMD Serono, Inc. | $22.26 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120215896 | CMS |
| JAZZ PHARMACEUTICALS INC. | $34.82 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150240725 | CMS |
| Lilly USA, LLC | $18.30 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136035038 | CMS |
| Microtransponder, Inc. | $36.89 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082718454 | CMS |
| Neurelis, Inc. | $15.51 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145632675 | CMS |
| Neurelis, Inc. | $21.47 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145632679 | CMS |
| Neurocrine Biosciences, Inc. | $18.84 | 05/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150862790 | CMS |
| Neurocrine Biosciences, Inc. | $13.61 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150878380 | CMS |
| Neurocrine Biosciences, Inc. | $19.25 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150861447 | CMS |
| Neurocrine Biosciences, Inc. | $14.88 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150875466 | CMS |
| PFIZER INC. | $17.60 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132107054 | CMS |
| Philips North America LLC | $29.55 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146894061 | CMS |
| REVANCE THERAPEUTICS, INC. | $20.98 | 05/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147912166 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.59 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137478425 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.